Farther Finance Advisors’s Protara Therapeutics TARA Stock Holding History

Farther Finance Advisors’s Portfolio TARA Stock Details TARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$180	Sell	59 -33	-36%	-$129	﹤0.01%	5893
2026 Q2	$351	Sell	92 -25	-21%	-$119	﹤0.01%	5606
2026 Q1	$590	Buy	117 +62	+113%	+$367	﹤0.01%	5233
2025 Q4	$293	Hold	55	–	–	﹤0.01%	5143
2025 Q3	$239	Buy	+55	New	+$178	﹤0.01%	4685

Other funds holding TARA

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors's TARA Position: Q3 2026 in Review

Farther Finance Advisors reduced its Protara Therapeutics (TARA) stake by 36% in Q3 2026, selling an estimated $129 and leaving 59 shares worth $180. The position accounts for ﹤0.01% of the portfolio, ranked #5893.

Farther Finance Advisors first reported a position in TARA in Q3 2025 and has held it in 5 quarters since. The position peaked at $590 in Q1 2026. 3 funds tracked by Wall St. Rank hold TARA as of Q3 2026.

Farther Finance Advisors held 59 shares of Protara Therapeutics worth $180 as of Q3 2026.
Farther Finance Advisors sold 33 Protara Therapeutics shares in Q3 2026, an estimated $129.
Protara Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5893 holding.
Farther Finance Advisors first reported a position in Protara Therapeutics in Q3 2025 and has held it in 5 quarters since.
Farther Finance Advisors's Protara Therapeutics position peaked at $590 in Q1 2026.
3 funds tracked by Wall St. Rank held Protara Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.